Company / Shares Outstanding
Celldex Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
66.5M
FY2025
5-year range
46.7M / 66.5M
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#102 of 165
Health Care
What the data says
At 66549442.00, Celldex Therapeutics, Inc.'s shares outstanding ranks #64 of 165 in the Health Care sector. Shares Outstanding has increased for 7 consecutive years, from 9234693.00 in FY2018 to 66549442.00 in FY2025.
Based on SEC 10-K filings.
66549442.00 in FY2025 with a 5-year CAGR of +10.9%.
Increased from 55883377.00 to 66549442.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Sector benchmark
#64 of 165 in Health CareTop 38% of 165This company 66.5M Sector average 171.0M
▼
-61.1% below sector average
Key checks
Key Insights
- Celldex Therapeutics, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 0.3% year-over-year.
- Ranks #102 out of 165 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 66.5M | +0.3% |
| FY2024 | 66.4M | +18.8% |
| FY2023 | 55.9M | +18.4% |
| FY2022 | 47.2M | +1.0% |
| FY2021 | 46.7M | +18.0% |
| FY2020 | 39.6M | +133.3% |
| FY2019 | 17.0M | +83.8% |
| FY2018 | 9.2M | -92.3% |
| FY2017 | 120.5M | +0.0% |
| FY2016 | 120.5M | +22.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026